Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model

Biomaterials

Volumn 27, Issue 31, 2006, Pages 5409-5419

  Wei, Hao Ji ^a   Chen, Sung Ching ^b   Chang, Yen ^a   Hwang, Shiaw Min ^c   Lin, Wei Wen ^d   Lai, Po Hong ^b   Chiang, Huihua Kenny ^e   Hsu, Lee Feng ^c   Yang, Hang Hsing ^b   Sung, Hsing Wen ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Cardiomyocytes; Mesenchymal stem cells; Myocardial tissue regeneration; Porous acellular bovine pericardium

Indexed keywords

CAPILLARITY; ENDOCRINOLOGY; TISSUE CULTURE;

ANGIOGENESIS; BRDU-LABELED MESENCHYMAL STEM CELLS (MSC); CARDIOMYOCYTES; MESENCHYMAL STEM CELLS; MYOCARDIAL TISSUE REGENERATION; POROUS ACELLULAR BOVINE PERICARDIUM;

CELL CULTURE;

ALPHA SMOOTH MUSCLE ACTIN; BROXURIDINE; GLYCOSAMINOGLYCAN;

ADHESION; ANEURYSM; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL ISOLATION; CONTROLLED STUDY; COW; ELECTROCARDIOGRAM; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HEART MUSCLE CELL; MESENCHYMAL STEM CELL; MYOCARDIAL DISEASE; NONHUMAN; PERICARDIUM; POROSITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; THROMBOGENESIS; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT OUTCOME;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARDIOMYOPATHIES; CATTLE; CELL-FREE SYSTEM; CELLS, CULTURED; COCULTURE TECHNIQUES; MATERIALS TESTING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PERICARDIUM; POROSITY; RATS; RATS, INBRED LEW; REGENERATION; TISSUE ENGINEERING; TRANSPLANTATION, ISOGENEIC;

ANIMALIA; BOS TAURUS; THROMBUS;

EID: 33746255992     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.06.022     Document Type: Article

References (50)

1. Takemura G., Ohno M., Hayakawa Y., Misao J., Kanoh M., Ohno A., et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infraction. Circ Res 82 (1998) 1130-1138
2. Jugdutt B.I. Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy. Can J Cardiol 9 (1993) 103-114
3. Akhyari P., Fedak P.W.M., Weisel R.D., Lee T.Y.J., Verma S., and Mickle D.A.G. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106 suppl I (2002) I137-I142
4. Ozawa T., Mickle D.A.G., Weisel R.D., Koyama N., Wong H., and Ozawa S. Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. J Thorac Cardiovasc Surg 124 (2002) 1157-1164
5. Courtman D.W., Pereira C.A., Kashef V., McComb D., Lee J.M., and Wilson G.J. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 28 (1994) 655-702
6. Chang Y., Tsai C.C., Liang H.C., and Sung H.W. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 23 (2002) 2447-2557
7. Sung H.W., Chen C.N., Huang R.N., Hsu J.C., and Chang W.H. In vitro surface characterization of a biological patch fixed with a naturally occurring crosslinking agent. Biomaterials 21 (2000) 1353-1362
8. Sung H.W., Huang R.N., Huang L.L.H., and Tsai C.C. In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Edn 10 (1999) 63-71
9. Chang Y., Tsai C.C., Liang H.C., and Sung H.W. Reconstruction of the right ventricular outflow tract with a bovine jugular vein graft fixed with a naturally occurring crosslinking agent (genipin) in a canine model. J Thorac Cardiovasc Surg 122 (2001) 1208-1218
10. Lai P.H., Chang Y., Liang H.C., Chen S.C., Wei H.J., and Sung H.W. Peritoneal regeneration induced by an acellular bovine pericardial patch in the repair of abdominal wall defects. J Surg Res 127 (2005) 85-92
11. Chang Y., Hsu C.K., Wei H.J., Chen S.C., Liang H.C., Lai P.H., et al. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: in vitro ultrastructural, biochemical, and mechanical analyses and in vivo evaluation. J Biotech 120 (2005) 207-219
12. Kim B.S., Baez C.E., and Atala A. Biomaterials for tissue engineering. World J Urol 18 (2000) 2
13. Pasumarthi K.B., and Field L.J. Cardiomyocyte cell cycle regulation. Circ Res 90 (2002) 1044-1054
14. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
15. Minguell J.J., Erices A., and Conget P. Mesenchymal stem cells. Exp Biol Med 226 (2001) 507-520
16. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infracted myocardium. Nature 410 (2001) 701-705
17. Ryu J.H., Kim I.K., Cho S.W., Cho M.C., Hwang K.K., and Piao H. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infracted myocardium. Biomaterials 26 (2005) 319-326
18. Wei H.J., Chang Y., Linag H.C., Huang Y.C., Chang Y., and Sung H.W. Construction of varying porous structures in acellular bovine pericardia as a tissue-engineering extracellular matrix. Biomaterials 26 (2005) 1905-1913
19. Chang Y., Lee M.H., Liang H.C., Hsu C.K., and Sung H.W. Acellular bovine pericardia with distinct porous structures fixed with genipin as an extracellular matrix. Tissue Eng 10 (2004) 881-892
20. Ramshaw A.M., Casagranda F., White J.F., Edwards G.A., Hunt J.A., Williams D.F., et al. Effects of mesh modification on the structure of a mandrel-grown biosynthetic vascular prosthesis. J Biomed Mater Res 47 (1999) 309-315
21. Martin I., Shastri V.P., Padera R.F., Yang J., Mackay A.J., Langer R., et al. Selective differentiation of mammalian bone marrow stromal cells cultured on three-dimensional polymer foams. J Biomed Mater Res 55 (2001) 229-235
22. Sung H.W., Chang Y., Chiu C.T., Chen C.N., and Liang H.C. Crosslinking characteristics and mechanical properties of a bovine pericardium fixed with a naturally occurring crosslinking agent. J Biomed Mater Res 47 (1999) 116-126
23. Wakitani S., Saito T., and Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-aza-cytidine. Muscle Nerve 18 (1995) 1417-1426
24. Tomita S., Li R.K., Weisel R.D., Mickle D.A.G., Kim E.J., Sakai T., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100 suppl (1999) II247-II256
25. Krupnick A.S., Kreisel D., Engels F.H., Szeto W.Y., Plappert T., Popma S.H., et al. A novel small animal model of left ventricular tissue engineering. J Heart Lung Transplant 21 (2002) 233-243
26. Ozawa T., Mickle D.A.G., Weisel R.D., Koyama N., Ozawa S., and Li R.K. Optimal biomaterial for creation of autologous cardiac grafts. Circulation 106 Suppl I (2002) I176-I182
27. Chiang H.K., Chu C.W., Chen G.Y., and Kuo C.D. A new 3-D display method for 12-lead ECG. IEEE Trans Biomed Eng 48 (2001) 1195-1202
28. Miyagawa S., Sawa Y., Taketani S., Kawaguchi N., Nakamura T., Matsuura N., et al. Myocardial regeneration therapy for heart failure hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 105 (2002) 2556-2561
29. Prophet E.B., Mills B., Arrington J.B., and Sobin L.H. Laboratory methods in histotechnology. 2nd ed (1994), American Registry of Pathology, Washington p. 136
30. Allaire E., Guettier C., Bruneval P., Plissonnier D., and Michel J.B. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 19 (1994) 446-456
31. Hsieh P.C.H., Davis M.E., Gannon J., MacGillivray C., and Lee R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 116 (2006) 237-248
32. Bader A., Schiling T., and Teebken O.E. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Euro J Cardiothorac Surg 14 (1998) 279-284
33. Courtman D.W., Errett B.F., and Wilson G.J. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res 55 (2001) 576-586
34. Li R.K., Jia Z.Q., and Weisel R.D. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62 (1996) 654-660
35. Shimizu T., Yamato M., Kikuchi A., and Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24 (2003) 2309-2316
36. Matsubayashi K., Fedak P.W.M., Mickle D.A.G., Richard D., Weisel R.D., Ozawa T., et al. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 108 Suppl II (2003) II219-II225
37. Macchi E., Cavalieri M., Stilli D., Musso E., Baruffi S., and Olivetti G. High-density epicardial mapping during current injection and ventricular activation in rat hearts. Am J Physiol 275 (1998) H1886-H1897
38. Whitaker D., Papadimitriou J.M., and Walters M. The mesothelium: its fibrinolytic properties. J Pathol 136 (1982) 291-299
39. Elmadbouh I., Chen Y., Louedec L., Silberman S., Pouzet B., Meilhac O., et al. Mesothelial cells transplantation in the infarct scar induces neovascularization and improves heart function. Cardiovasc Res 68 (2005) 307-317
40. Scott S.M., Barth M.G., Gaddy L.R., and Ahl Jr. E.T. The role of circulating cells in the healing of vascular prostheses. J Vasc Surg 19 (1994) 585-593
41. Malone J.M., Brendel K., Duhamel R.C., and Reinert R.L. Detergent-extracted small-diameter vascular prostheses. J Vasc Surg 1 (1984) 181-191
42. Graham L.M., Vinter D.W., Ford J.W., Kahn R.H., Burkel W.E., and Stanley J.C. Endothelial cell seeding of prosthetic vascular grafts. Early experimental studies with cultured autologous canine endothelium. Arch Surg 115 (1980) 929-933
43. Sue E., Matsuno H., Ishisaki A., Kitajima Y., and Kozawa O. Lack of plasminogen activator inhibitor-1 enhances the preventive effect of DX-9065a, a selective factor Xa inhibitor, on venous thrombus and acute pulmonary embolism in mice. Pathophysiol Haemost Thromb 33 (2003) 206-213
44. Shinoka T., Ma P.X., Shum-Tim D., Breuer C.K., Cusick R.A., and Zund G. Tissue-engineered heart valves: autologous valve leaflet replacement study in a lamb model. Circulation 94 9 Suppl (1996) II164-II168
45. Wang J.S., Shum-Tim D., and Galipeau J. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120 (2000) 999-1005
46. Davani S., Marandin A., Mersin N., Royer B., Kantelip B., Hervé P., et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 Suppl II (2003) II253-II258
47. Pitterger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95 (2004) 9-20
48. Cipriano P.R., Billingham M.E., Oyer P.E., Kutsche L.M., and Stinson E.B. Calcification of porcine heart valves: a radiographic and light microscopy study. Circulation 66 (1982) 1100-1104
49. Schoen F.J., Harasaki H., Kim K.M., Anderson H.C., and Levy R.J. Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 22 (1988) 11-36
50. Valente M., Bortolotti U., and Thiene G. Ultrastrutural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 119 (1985) 12-21